Myosin II regulates the shape of three-dimensional intestinal epithelial cysts

J Cell Sci. 2008 Jun 1;121(11):1803-14. doi: 10.1242/jcs.015842. Epub 2008 May 6.

Abstract

The development of luminal organs begins with the formation of spherical cysts composed of a single layer of epithelial cells. Using a model three-dimensional cell culture, this study examines the role of a cytoskeletal motor, myosin II, in cyst formation. Caco-2 and SK-CO15 intestinal epithelial cells were embedded into Matrigel, and myosin II was inhibited by blebbistatin or siRNA-mediated knockdown. Whereas control cells formed spherical cysts with a smooth surface, inhibition of myosin II induced the outgrowth of F-actin-rich surface protrusions. The development of these protrusions was abrogated after inhibition of F-actin polymerization or of phospholipase C (PLC) activity, as well as after overexpression of a dominant-negative ADF/cofilin. Surface protrusions were enriched in microtubules and their formation was prevented by microtubule depolymerization. Myosin II inhibition caused a loss of peripheral F-actin bundles and a submembranous extension of cortical microtubules. Our findings suggest that inhibition of myosin II eliminates the cortical F-actin barrier, allowing microtubules to reach and activate PLC at the plasma membrane. PLC-dependent stimulation of ADF/cofilin creates actin-filament barbed ends and promotes the outgrowth of F-actin-rich protrusions. We conclude that myosin II regulates the spherical shape of epithelial cysts by controlling actin polymerization at the cyst surface.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / metabolism*
  • Actins / metabolism
  • Caco-2 Cells
  • Cell Polarity / physiology
  • Cell Shape / drug effects
  • Cell Shape / physiology*
  • Cofilin 1 / metabolism
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Humans
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / embryology*
  • Intestinal Mucosa / metabolism*
  • Myosin Type II / genetics
  • Myosin Type II / metabolism*
  • Nocodazole / pharmacology
  • Organ Culture Techniques
  • Polymers / metabolism
  • RNA Stability
  • Type C Phospholipases / metabolism

Substances

  • Actins
  • Cofilin 1
  • Heterocyclic Compounds, 4 or More Rings
  • Polymers
  • blebbistatin
  • Type C Phospholipases
  • Myosin Type II
  • Nocodazole